A Single Patient Compassionate Use of MBM-02 (Tempol) for the Treatment of Prostate Cancer
NCT04337099
·
clinicaltrials.gov ↗
AVAILABLE
Status
INDUSTRY
Sponsor class
Conditions
Prostate Cancer
Interventions
DRUG:
MBM-02 (Tempol)
Sponsor
Matrix Biomed, Inc.